P. Harper

2.1k total citations
43 papers, 1.1k citations indexed

About

P. Harper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, P. Harper has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in P. Harper's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). P. Harper is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). P. Harper collaborates with scholars based in United Kingdom, United States and Germany. P. Harper's co-authors include R L Souhami, SG Spiro, R L Souhami, L. E. James, R.D. Rubens, N.H. Gower, N Dobbs, M C Ruiz de Elvira, R.M. Rudd and Alan Lamont and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

P. Harper

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Harper United Kingdom 18 551 278 278 210 154 43 1.1k
Paul Y. Holoye United States 22 606 1.1× 560 2.0× 358 1.3× 253 1.2× 474 3.1× 47 1.5k
Jyoti Bajpai India 18 441 0.8× 382 1.4× 137 0.5× 122 0.6× 198 1.3× 123 1.1k
Timothy R. Asmis Canada 19 758 1.4× 420 1.5× 212 0.8× 258 1.2× 237 1.5× 66 1.3k
Letizia Gnetti Italy 22 693 1.3× 704 2.5× 216 0.8× 374 1.8× 216 1.4× 123 1.5k
Emanuele Naglieri Italy 15 336 0.6× 200 0.7× 95 0.3× 210 1.0× 245 1.6× 42 1.0k
Salitha Reddy United States 18 571 1.0× 552 2.0× 120 0.4× 77 0.4× 200 1.3× 29 1.3k
Abdurrahman Işıkdoğan Türkiye 19 537 1.0× 424 1.5× 102 0.4× 204 1.0× 204 1.3× 146 1.2k
Samuel S. Dychter United States 14 544 1.0× 268 1.0× 180 0.6× 256 1.2× 127 0.8× 25 1.2k
E Silverberg United States 8 415 0.8× 320 1.2× 124 0.4× 126 0.6× 253 1.6× 8 962
Pınar Saip Türkiye 21 606 1.1× 520 1.9× 135 0.5× 288 1.4× 337 2.2× 115 1.6k

Countries citing papers authored by P. Harper

Since Specialization
Citations

This map shows the geographic impact of P. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Harper more than expected).

Fields of papers citing papers by P. Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Harper. The network helps show where P. Harper may publish in the future.

Co-authorship network of co-authors of P. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of P. Harper. A scholar is included among the top collaborators of P. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Harper. P. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souhami, R L, Helena Earl, C. M. Ash, et al.. (2015). Prognostic Factors in Patients with Small-Cell Lung Cancer: Preliminary Results from a Large Randomised Study. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 77–82.
2.
Souhami, R L, C. M. Ash, Helena Earl, et al.. (2015). Identification of Patients at High Risk of Chemotherapy-Induced Toxicity in Small-Cell Lung Cancer. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 220–225. 1 indexed citations
3.
Abdel‐Rahman, Manar E., J. Butler, Matthew R. Sydes, et al.. (2014). No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. British Journal of Cancer. 111(3). 589–597. 13 indexed citations
4.
Tempero, Margaret A., Jordan Berlin, Michel Ducreux, et al.. (2011). Pancreatic cancer treatment and research: an international expert panel discussion. Annals of Oncology. 22(7). 1500–1506. 47 indexed citations
5.
Schaefer, Deanna M. W., et al.. (2007). Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia. Veterinary and Comparative Oncology. 5(3). 145–155. 24 indexed citations
6.
Lo, Sing Kai, Desmond Yip, Myles Leslie, & P. Harper. (1999). 5‐FLUOROURACIL‐INDUCED ERYTHEMA MULTIFORME. International Journal of Clinical Practice. 53(3). 219–221. 5 indexed citations
7.
Gore, Martin, Paul N. Mainwaring, Roger A’Hern, et al.. (1998). Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group.. Journal of Clinical Oncology. 16(7). 2426–2434. 97 indexed citations
8.
Souhami, R L, SG Spiro, R.M. Rudd, et al.. (1997). Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy. JNCI Journal of the National Cancer Institute. 89(8). 577–580. 143 indexed citations
9.
Gower, N.H., R.M. Rudd, M C Ruiz de Elvira, et al.. (1995). Assessment of ’quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Annals of Oncology. 6(6). 575–580. 23 indexed citations
10.
Dobbs, N, et al.. (1995). Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemotherapy and Pharmacology. 36(6). 473–476. 95 indexed citations
11.
Perren, Timothy, E. Wiltshaw, P. Harper, et al.. (1993). A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. British Journal of Cancer. 68(6). 1190–1194. 8 indexed citations
12.
Twelves, C.J., N Dobbs, L. A. SUMMERS, et al.. (1992). Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests. British Journal of Cancer. 66(4). 765–769. 42 indexed citations
13.
Earl, Helena, R.M. Rudd, SG Spiro, et al.. (1991). A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer. 64(3). 566–572. 39 indexed citations
14.
Johnson, Philip J., Cem Kalaycı, Nicola Dobbs, et al.. (1991). Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol. Journal of Hepatology. 13(1). 120–127. 78 indexed citations
15.
Goldstraw, Peter, G. Bureau, G Dabouis, et al.. (1991). Pretreatment minimal staging for non-small cell lung cancers: a consensus report. Lung Cancer. 7(1-2). 7–9. 9 indexed citations
16.
Earl, Helena, R L Souhami, C. M. Ash, et al.. (1989). Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. British Journal of Cancer. 59(5). 801–804. 39 indexed citations
17.
Gillies, Harold, H. J. Rogers, J.H. Johnston, P. Harper, & Chris Rudge. (1985). Is repeated flushing of Hickman catheters necessary?. BMJ. 290(6483). 1708–1708. 22 indexed citations
18.
Souhami, R L, J S Tobias, I Bradbury, et al.. (1984). Radiotherapy in small cell cancer of the lung. BMJ. 289(6438). 190.1–190. 1 indexed citations
19.
Spiro, SG, Sanjay Shah, P. Harper, et al.. (1983). Treatment of obstruction of the superior vena cava by combination chemotherapy with and without irradiation in small-cell carcinoma of the bronchus.. Thorax. 38(7). 501–505. 39 indexed citations
20.
Harper, P., J Pringle, & R L Souhami. (1981). Neuroepithelioma—a rare malignant peripheral nerve tumor of primitive origin: Report of two new cases and a review of the literature. Cancer. 48(10). 2282–2287. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Y. Holoye Breakdown of academic impact, for papers by Jyoti Bajpai Breakdown of academic impact, for papers by Timothy R. Asmis Breakdown of academic impact, for papers by Letizia Gnetti Breakdown of academic impact, for papers by Emanuele Naglieri Breakdown of academic impact, for papers by Salitha Reddy Breakdown of academic impact, for papers by Abdurrahman Işıkdoğan Breakdown of academic impact, for papers by Samuel S. Dychter Breakdown of academic impact, for papers by E Silverberg Breakdown of academic impact, for papers by Pınar Saip
Rankless by CCL
2026